Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041470
Status:
TERMINATED
Last Update Posted:
2017-07-17
First Post:
2002-07-09
Brief Title:
Navelbine Taxol Herceptin and Neupogen in Stage IV Breast Cancer A Phase I - II Trial
Sponsor:
University of Washington
Organization:
University of Washington
Organization Data
Organization:
University of Washington
Class:
OTHER
Study ID:
18245
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Washington
Lead Sponsor Class:
OTHER
Responsible Party:
Julie Ruth Gralow
Responsible Party Title:
Professor of Medicine MedicineOncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Washington
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |
| Amgen | INDUSTRY |
| Bristol-Myers Squibb | INDUSTRY |